The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTempleton Emerging Markets Regulatory News (TEM)

Share Price Information for Templeton Emerging Markets (TEM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.00
Bid: 161.60
Ask: 162.00
Change: -1.00 (-0.61%)
Spread: 0.40 (0.248%)
Open: 164.40
High: 164.40
Low: 161.40
Prev. Close: 163.00
TEM Live PriceLast checked at -
Templeton Emerging Markets is an Investment Trust

To provide long-term capital appreciation for private and institutional investors seeking exposure to global emerging markets, supported by both strong customer service and corporate governance.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on Templeton Emerging Markets

27 Jun 2022 07:00

RNS Number : 1716Q
Templeton Emerging Markets IT PLC
27 June 2022
 

London, UK, 27 June 2022

 

Edison issues review on Templeton Emerging Markets Investment Trust (TEM)

Templeton Emerging Markets Investment Trust (TEMIT) is a very large and well-established fund run by experienced managers, Chetan Sehgal (lead manager) and Andrew Ness. Despite a tough period of performance since Q221 due to macroeconomic developments, the managers are sticking to their long-term strategy of investing in companies with sustainable earnings power that are trading at a discount to their estimated intrinsic values. Sehgal and Ness remain positive on the prospects for emerging markets, which are home to a range of 'best-in-breed' companies including semiconductor manufacturers and low-cost commodity producers. The managers are further diversifying the portfolio in response to the new realities of rising interest rates, China's zero-COVID policy, the war in Ukraine and climate change.

TEMIT's shares are trading at a 12.9% discount to cum income NAV, which is wider than the 10.6% to 11.1% range of average discounts over the last one, three, five and 10 years. This may be due to the trust's relative underperformance since Q221; hence any improvement in TEMIT's results could result in a narrower discount. 

 

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5720 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEADKLAFNAEFA
Date   Source Headline
13th Jan 20239:24 amRNSNet Asset Value(s)
12th Jan 202310:39 amRNSNet Asset Value(s)
11th Jan 20239:19 amRNSNet Asset Value(s)
10th Jan 20234:58 pmRNSTransaction in Own Shares
10th Jan 20239:39 amRNSNet Asset Value(s)
9th Jan 20239:29 amRNSNet Asset Value(s)
6th Jan 20239:41 amRNSNet Asset Value(s)
5th Jan 20239:21 amRNSNet Asset Value(s)
4th Jan 20238:58 amRNSNet Asset Value(s)
3rd Jan 202310:57 amRNSTotal Voting Rights
3rd Jan 202310:04 amRNSNet Asset Value(s)
30th Dec 20221:15 pmRNSTransaction in Own Shares
30th Dec 20229:34 amRNSNet Asset Value(s)
29th Dec 20229:33 amRNSNet Asset Value(s)
28th Dec 20224:56 pmRNSTransaction in Own Shares
28th Dec 20229:12 amRNSNet Asset Value(s)
23rd Dec 20229:08 amRNSNet Asset Value(s)
22nd Dec 20224:59 pmRNSTransaction in Own Shares
22nd Dec 20229:18 amRNSNet Asset Value(s)
21st Dec 20229:20 amRNSNet Asset Value(s)
20th Dec 20225:01 pmRNSTransaction in Own Shares
20th Dec 202210:04 amRNSNet Asset Value(s)
20th Dec 20229:40 amRNSPortfolio Update
19th Dec 20229:37 amRNSNet Asset Value(s)
16th Dec 20229:41 amRNSNet Asset Value(s)
15th Dec 20225:25 pmRNSTransaction in Own Shares
15th Dec 20229:27 amRNSNet Asset Value(s)
14th Dec 20229:20 amRNSNet Asset Value(s)
13th Dec 20229:24 amRNSNet Asset Value(s)
12th Dec 20229:11 amRNSNet Asset Value(s)
9th Dec 20225:03 pmRNSTransaction in Own Shares
9th Dec 20221:59 pmRNSDirector/PDMR Shareholding
9th Dec 202211:49 amRNSNet Asset Value(s)
8th Dec 20224:56 pmRNSDividend Declaration
8th Dec 20224:52 pmRNSStatement of Half-Yearly Results to 30 Sept 22
8th Dec 20229:19 amRNSNet Asset Value(s)
7th Dec 20224:59 pmRNSTransaction in Own Shares
7th Dec 20229:11 amRNSNet Asset Value(s)
6th Dec 20225:00 pmRNSTransaction in Own Shares
6th Dec 20229:21 amRNSNet Asset Value(s)
5th Dec 20224:59 pmRNSTransaction in Own Shares
5th Dec 20229:13 amRNSNet Asset Value(s)
2nd Dec 20229:51 amRNSNet Asset Value(s)
1st Dec 20229:46 amRNSNet Asset Value(s)
1st Dec 20229:34 amRNSTotal Voting Rights
30th Nov 20225:01 pmRNSTransaction in Own Shares
30th Nov 202210:01 amRNSNet Asset Value(s)
29th Nov 20225:10 pmRNSTransaction in Own Shares
29th Nov 20229:17 amRNSNet Asset Value(s)
28th Nov 20229:27 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.